PMA

P180046: Axonics Sacral Neuromodulation System

FDA PMA · Stimulator, electrical, implantable, for incontinence · Boston Scientific Corporation

Key facts

PMA number P180046
Trade name Axonics Sacral Neuromodulation System
Generic name Stimulator, electrical, implantable, for incontinence
Applicant Boston Scientific Corporation
Owner/operator Boston Scientific Corporation
Product code EZW
Approval date Nov 13, 2019
Docket number 19M-5393
Notice date Nov 14, 2019
Establishment registration 3002968685

At a glance

  • 100–999 Supplements
  • Aug 7, 2026 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 1–9 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals